📰 Dtx Pharma News
Page 4 - Dtx Pharma News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Dtx Pharma. Real-time updates on events, politics, business and more.
May 25, 2023
Chia Tai Tianqing Pharmaceutical Group Co., Ltd., a Sino Biopharm’s subsidiary, receives IND approval from the NMPA to initiate the clinical development in mainland China of lanifibranor in... | May 25, 2023
May 25, 2023
FinancialContent fully hosted finance channel
March 9, 2023
invoX Pharma Limited ("invoX"), a U.K.-based wholly-owned subsidiary of Sino Biopharmaceutical Limited ("Sino Biopharm") (HKEX 1177 HK) with an advancing pipeline of innovative products, today announces
March 7, 2023
Parties expect the merger to be completed promptly following the successful completion of the ongoing Tender OfferCAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., March 07, 2023(NASDAQ: FSTX) ("F-star"
December 22, 2022
This interview highlights Dr Arthur Suckow’s insights into how his team uses RNA therapeutics to treat rare diseases.
December 1, 2022
/PRNewswire/ -- Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies long-term...
November 1, 2022
RNA interference clinical trial pipeline constitutes 85+ key companies continuously working towards developing 100+ RNA interference therapies, analyzes DelveInsight LAS VEGAS, Nov. 1,
November 1, 2022
/PRNewswire/ -- DelveInsights RNA Interference Competitive Landscape – 2022 report provides comprehensive global coverage of available, marketed, and...
September 21, 2022
Investegate announcements from INVENTIVA, Inventiva and Sino Biopharm announce licensing and collaboration agreement to develop and commercialize lanifibranor in Greater China
September 21, 2022
Sino Biopharm a leading Chinese pharmaceutical group, through CTTQ will oversee the development and commercialization of lanifibranor in Greater ChinaLanifibranor is an orally-available small molecule